JC virus - DNA detection by PCR - CSF

JC Virus - DNA Detection by PCR - CSF is an advanced molecular diagnostic test used to detect the presence of JC Virus (JCV) DNA in cerebrospinal fluid (CSF). The test utilizes highly sensitive Polymerase Chain Reaction (PCR) technology to identify active JC Virus infection affecting the central nervous system and provide rapid molecular confirmation of viral involvement.

JC Virus is a common human polyomavirus that remains dormant in most healthy individuals throughout life. However, in immunocompromised patients, particularly those with HIV/AIDS, hematological malignancies, organ transplantation, or immunosuppressive therapy, the virus may reactivate and cause Progressive Multifocal Leukoencephalopathy (PML), a serious and potentially life-threatening neurological disorder.

Benefits of the Test

• Highly sensitive detection of JC Virus DNA in CSF.
• Supports diagnosis of Progressive Multifocal Leukoencephalopathy (PML).
• Provides direct evidence of active central nervous system infection.
• Assists in evaluation of unexplained neurological symptoms.
• Useful for immunocompromised patients.
• Supports timely diagnosis and clinical management.
• Offers rapid molecular confirmation of infection.
• Provides reliable and accurate diagnostic results.

Why Doctors Recommend This Test

Doctors recommend JC Virus PCR testing in CSF for patients with unexplained neurological symptoms, suspected Progressive Multifocal Leukoencephalopathy, abnormal brain MRI findings, HIV/AIDS, organ transplant recipients, cancer patients, and individuals receiving immunosuppressive therapy.

The test helps establish a definitive molecular diagnosis and supports early medical intervention when JC Virus-related neurological disease is suspected.

Preparation Before Test

• No fasting is generally required.
• A cerebrospinal fluid (CSF) sample is collected through lumbar puncture by a qualified healthcare professional.
• Inform your doctor about current medications and immunosuppressive therapy.
• Provide relevant neurological and medical history.
• Follow all pre-procedure and post-procedure instructions carefully.
• Ensure prompt transportation of the specimen to the laboratory.

Normal Reporting Time

Most JC Virus DNA Detection by PCR - CSF reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final PCR analysis, validation, and reporting are generally completed within a few working days depending on laboratory protocols and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected Progressive Multifocal Leukoencephalopathy (PML).
• Individuals with unexplained neurological deficits.
• Patients with HIV/AIDS.
• Organ and stem cell transplant recipients.
• Individuals receiving immunosuppressive therapy.
• Patients with abnormal MRI findings suggestive of PML.
• People with progressive cognitive or neurological decline.
• Individuals requiring molecular confirmation of JC Virus infection.

Detailed Information

JC Virus (John Cunningham Virus) is a human polyomavirus that infects a large proportion of the population during childhood. Following primary infection, the virus remains latent in various tissues, including the kidneys, bone marrow, and lymphoid organs.

In healthy individuals, JC Virus rarely causes disease because the immune system effectively suppresses viral activity. However, when immune function becomes severely compromised, the virus can reactivate and spread to the central nervous system.

Reactivation within the brain can lead to Progressive Multifocal Leukoencephalopathy (PML), a demyelinating disease characterized by destruction of the protective myelin sheath surrounding nerve fibers. Symptoms may include weakness, visual disturbances, speech difficulties, cognitive impairment, balance problems, personality changes, and progressive neurological deterioration.

Detection of JC Virus DNA in cerebrospinal fluid is considered one of the most important laboratory tools for supporting the diagnosis of PML. PCR testing directly identifies viral genetic material and provides evidence of active infection within the central nervous system.

The test offers excellent sensitivity and specificity and is commonly used in conjunction with neurological examination, MRI imaging, immune status assessment, and other laboratory investigations. Early diagnosis is critical because timely medical intervention may help improve clinical outcomes.

Results should always be interpreted alongside clinical findings, neuroimaging studies, immunological evaluation, and physician assessment. Additional investigations may be recommended depending on the patient's clinical condition.

At Focus Diagnostics, JC Virus DNA Detection by PCR - CSF testing is performed using advanced molecular diagnostic platforms, validated PCR methodologies, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful infectious disease diagnostic results.